Institution identification

PURI

https://redirect.ema.europa.eu/resource/41205

Institution ID

41205

Institution full name and acronym

Real World Solutions, PRA Real World Solutions

Institution countries

France
Germany

Type of institution

Non-Pharmaceutical company

Institution website

ENCePP partner

Yes
Institution description
PRA is a global biopharmaceutical services provider that offers clinical development as well as real-world and late-phase research expertise. PRA’s Real World Solutions group (RWS) is specialized in the design, management and execution of prospective non-interventional studies, outcome evaluation, post-marketing studies, and retrospective research for pharmaceutical, device and biotech companies. RWS is well-versed in global post-authorisation regulatory requirements and pharmacovigilance. RWS specifically has conducted many mandated and voluntarily conducted post-authorisation safety studies (PASS) including drug utilization studies and studies to measure the effectiveness of risk minimization/ mitigation strategies.
Institution details
Experience with collecting data directly from individual patients or respondents:
Yes
Interest in carrying out research that is funded by pharmaceutical companies:
Yes

Contact